medicare coverage of glp 1 New GLP-1 Bridge Program Access to GLP-1s for Medicare
Description
In another phase II trial with 52 people with clinical evidence of NASH, liraglutide 1.8 mg treatment led to histological improvement of NASH [79]
Shed reserves the right to modify or discontinue the program with 30 days' notice to active participants
Approvals are typically valid for 6 to 12 months and may need to be renewed
doi: 10.1038/s41598-023-34070-6
Diabetes in older adults
It makes it possible to dream that type 2 diabetes could be treated to the point of complete normalisation' (Holst 2024)
